Main useUsed to slow progression of mild cognitive impairment or mild dementia due to Alzheimer’s disease.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
- Japan product name
- レケンビ点滴静注200mg／500mg
- Brand
- Leqembi
- Generic name
- Lecanemab
- Japanese generic name
- レカネマブ
- Chinese name
- 仑卡奈单抗
- Marketing authorization holder
- エーザイ株式会社
- Strengths
- 200 mg / 500 mg
- Dosage form
- IV infusion
- Therapeutic area
- الأعصاب
- Regulatory status
- Rx
- Label updated
- 2026-09-16
- TOKYO MEDI verified
- 2026-09-22
مصدر رسمي
These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.